[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20020131L - Diacylhydrazinderivater - Google Patents

Diacylhydrazinderivater

Info

Publication number
NO20020131L
NO20020131L NO20020131A NO20020131A NO20020131L NO 20020131 L NO20020131 L NO 20020131L NO 20020131 A NO20020131 A NO 20020131A NO 20020131 A NO20020131 A NO 20020131A NO 20020131 L NO20020131 L NO 20020131L
Authority
NO
Norway
Prior art keywords
angioplasty
fight
arteriosclerosis
restenosis
thrombosis
Prior art date
Application number
NO20020131A
Other languages
English (en)
Other versions
NO20020131D0 (no
Inventor
Guenter Hoelzemann
Simon Goodman
Horst Kessler
Christoph Gibson
Gabor Sulyok
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20020131D0 publication Critical patent/NO20020131D0/no
Publication of NO20020131L publication Critical patent/NO20020131L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/06—Compounds containing any of the groups, e.g. semicarbazides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/02—Compounds containing any of the groups, e.g. carbazates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Diacylhydrazinderivater med den generelle formel I. hvor X, Y, Z, R, R2 oghar betyd-ningene angitt i krav l, og de fysio-logisk akseptable saltene eller solvatene derav, som er integrininhibi-torer og kan anvendes til å bekjempe tromboser, hjerteinfarkt, koronare hj ertesykdommer, arteriosklerose, betennelser, tumorer, osteoporose, infeksjoner og restenose etter angio-plasti, eller under patologiske prosesser som opprettholdes eller spres ved hjelp av angiogenese.
NO20020131A 1999-07-14 2002-01-11 Diacylhydrazinderivater NO20020131L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19932796A DE19932796A1 (de) 1999-07-14 1999-07-14 Diacylhydrazinderivate
PCT/EP2000/006307 WO2001005753A1 (de) 1999-07-14 2000-07-05 Diacylhydrazinderivate

Publications (2)

Publication Number Publication Date
NO20020131D0 NO20020131D0 (no) 2002-01-11
NO20020131L true NO20020131L (no) 2002-03-12

Family

ID=7914676

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020131A NO20020131L (no) 1999-07-14 2002-01-11 Diacylhydrazinderivater

Country Status (24)

Country Link
US (1) US6649613B1 (no)
EP (1) EP1194401B1 (no)
JP (1) JP2003505365A (no)
KR (1) KR20020022773A (no)
CN (1) CN1210256C (no)
AR (1) AR024741A1 (no)
AT (1) ATE249427T1 (no)
AU (1) AU762350B2 (no)
BR (1) BR0012391A (no)
CA (1) CA2379041A1 (no)
CZ (1) CZ200219A3 (no)
DE (2) DE19932796A1 (no)
DK (1) DK1194401T3 (no)
ES (1) ES2206275T3 (no)
HK (1) HK1047085A1 (no)
HU (1) HUP0202371A3 (no)
MX (1) MXPA02000415A (no)
NO (1) NO20020131L (no)
PL (1) PL352966A1 (no)
PT (1) PT1194401E (no)
SI (1) SI1194401T1 (no)
SK (1) SK192002A3 (no)
WO (1) WO2001005753A1 (no)
ZA (1) ZA200201225B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10040103A1 (de) 2000-08-17 2002-02-28 Merck Patent Gmbh Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften II
DE10040105A1 (de) 2000-08-17 2002-02-28 Merck Patent Gmbh Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften
FR2828884B1 (fr) * 2001-08-27 2005-09-09 Centre Nat Rech Scient Hydrazinopeptoides et leurs utilisations dans le traitement des cancers
DE10209692A1 (de) * 2002-03-06 2003-09-18 Merck Patent Gmbh Isochinolinderivate
DE10325049A1 (de) * 2003-06-02 2004-12-23 Merck Patent Gmbh Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften III
FR2859995A1 (fr) * 2003-09-23 2005-03-25 Centre Nat Rech Scient Hydrazinopeptoides reduits et leurs utilisations dans le traitement des cancers
MXPA06014092A (es) 2004-06-04 2007-03-15 Scripps Research Inst Composiciones y metodos para el tratamiento de enfermedades neovasculares.
US20060126018A1 (en) * 2004-12-10 2006-06-15 Junzhong Liang Methods and apparatus for wavefront sensing of human eyes
WO2008153801A1 (en) 2007-05-29 2008-12-18 Intrexon Corporation Chiral diachylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1361499A (en) * 1997-10-21 1999-05-10 Merck & Co., Inc. Azapeptide acids as cell adhesion inhibitors

Also Published As

Publication number Publication date
CN1210256C (zh) 2005-07-13
US6649613B1 (en) 2003-11-18
BR0012391A (pt) 2002-03-19
HUP0202371A3 (en) 2002-11-28
KR20020022773A (ko) 2002-03-27
EP1194401B1 (de) 2003-09-10
DK1194401T3 (da) 2004-08-16
SI1194401T1 (en) 2004-02-29
AR024741A1 (es) 2002-10-23
AU762350B2 (en) 2003-06-26
WO2001005753A1 (de) 2001-01-25
PT1194401E (pt) 2004-02-27
ES2206275T3 (es) 2004-05-16
JP2003505365A (ja) 2003-02-12
PL352966A1 (en) 2003-09-22
CZ200219A3 (cs) 2002-04-17
ZA200201225B (en) 2003-07-30
CA2379041A1 (en) 2001-01-25
HK1047085A1 (zh) 2003-02-07
HUP0202371A2 (en) 2002-10-28
DE19932796A1 (de) 2001-01-18
ATE249427T1 (de) 2003-09-15
AU6155100A (en) 2001-02-05
NO20020131D0 (no) 2002-01-11
MXPA02000415A (es) 2002-07-30
EP1194401A1 (de) 2002-04-10
CN1360568A (zh) 2002-07-24
SK192002A3 (en) 2002-06-04
DE50003660D1 (de) 2003-10-16

Similar Documents

Publication Publication Date Title
TW372232B (en) Phenylalanine derivatives
NO20010203L (no) Diacylhydrazinderivater som integrininhibitorer
NZ511927A (en) Phenylglycine derivatives
DK1259485T3 (da) Benzamider og beslægtede inhibitorer for faktor Xa
CA2280727A1 (en) Bicyclic amino acids
AR027398A1 (es) Derivados de indol-3-ilo
DK0939627T3 (da) Pentaflourbenzensulfonamider og analoger
NO20020131L (no) Diacylhydrazinderivater
WO2001056989A3 (en) Inhibitors of factor xa
MY133897A (en) N-(4-carb-amimidophenyl) glycineamide derivatives
RU94002323A (ru) Производные пиперазинов, способ их получения, фармацевтическая композиция, способ ее получения и использования
CA2348391A1 (en) Chromenone and chromanone derivatives as integrin inhibitors
WO2000048996A3 (de) Beta-alaninderivate
WO2001057021A3 (en) 2-[1H]-QUINOLONE AND 2-[1H]-QUINOXALONE INHIBITORS OF FACTOR Xa
MD523G2 (ro) Derivaţi noi ai triazolpirimidinei, antagonişti ai receptorilor angiotensinei II, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
PL361745A1 (en) Urea and urethane derivatives as integrin inhibitors
WO2002026720A3 (en) PIPERAZINE BASED INHIBITORS OF FACTOR Xa
BR0308195A (pt) Derivados de isoquinolina
BR0113374A (pt) Derivados de bifenila e seu uso como inibidores da integrina
WO2002026731A3 (en) Quaternary amidino based inhibitors of factor xa
WO2001010841A3 (de) Fluorenderivate als integrin inhibitoren
HUP0202710A2 (hu) Vitronektin receptor antagonisták, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
AR008717A1 (es) Derivados de peptidos ciclicos, sus enantiomeros y diastereomeros, un procedimiento para su preparacion, su empleo para preparar un medicamento, laspreparaciones farmaceuticas que los contienen y un procedimiento par obtener estas preparaciones farmaceuticas
CA2185394A1 (en) Biotinderivate
HUP0302822A2 (hu) Bifenilszármazékok és integrin inhibitorként történő alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application